As of April 16, 2025, Bicycle Therapeutics (BCYC) has a market cap of $0.54 billion USD. According to our data, Bicycle Therapeutics is ranked No.5871 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.54 B |
-19.03%
|
Dec 31, 2024 | $0.67 B |
-22.57%
|
Dec 29, 2023 | $0.86 B |
-38.92%
|
Dec 30, 2022 | $1.41 B |
-51.37%
|
Dec 31, 2021 | $2.89 B |
239.11%
|
Dec 31, 2020 | $0.85 B |
90.35%
|
Dec 31, 2019 | $0.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Molecular Partners
MOLN
|
$0.15 B |
2.343 M
|
![]() Switzerland
|
![]() Sutro Biopharma
STRO
|
$48.55 M |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.76 B |
-0.000 M
|
![]() Canada
|
![]() CytomX Therapeutics
CTMX
|
$50.58 M |
-0.000 M
|
![]() USA
|
![]() Pieris Pharmaceuticals
PIRS
|
$17.96 M |
0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Adagene
ADAG
|
$75.38 M |
-0.000 M
|
![]() China
|
![]() Mersana Therapeutics
MRSN
|
$43.43 M |
-0.000 M
|
![]() USA
|
![]() IGM Biosciences
IGMS
|
$75.91 M |
32.241 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.12 B |
0.000 M
|
![]() USA
|
![]() Xencor
XNCR
|
$0.67 B |
0.000 M
|
![]() USA
|
![]() Affimed
AFMD
|
$11.82 M |
0.000 M
|
![]() Germany
|
![]() Avidity Biosciences
RNA
|
$3.21 B |
0.000 M
|
![]() USA
|
Market Cap | = | BCYC Stock Price | * | BCYC Shares Outstanding |
= | $7.79 | * | 47.71 M | |
= | $0.54 B |